BIOTEST AG (BIO.DE) Stock Price, Quote, News and Overview
FRA:BIO - Deutsche Boerse Ag - DE0005227201 - Common Stock - Currency: EUR
BIO.DE Quote, Performance and Key Statistics
BIOTEST AG
FRA:BIO (2/3/2025, 7:00:00 PM)
40.8
-1 (-2.39%)
The current stock price of BIO.DE is 40.8 EUR. In the past year, price decreased by -1.89%.
BIO.DE Competitors/Peers
Symbol | Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| 4AB.DE | ABBVIE INC | 18.69 | 323.32B | ||
| AMG.DE | AMGEN INC | 14.96 | 149.57B | ||
| 1AMGN.MI | AMGEN INC | 14.81 | 148.09B | ||
| VX1.DE | VERTEX PHARMACEUTICALS INC | 937.76 | 118.34B | ||
| GIS.DE | GILEAD SCIENCES INC | 21.97 | 117.44B | ||
| ARGX.BR | ARGENX SE | N/A | 37.70B | ||
| 22UA.DE | BIONTECH SE-ADR | N/A | 27.07B | ||
| IDP.DE | BIOGEN INC | 8.75 | 20.15B | ||
| 1MRNA.MI | MODERNA INC | N/A | 13.08B | ||
| 0QF.DE | MODERNA INC | N/A | 12.75B | ||
| ALEMS.BR | EUROPEAN MEDICAL SOLUTIONS S | N/A | 9.95B | ||
| GLPG.AS | GALAPAGOS NV | 7 | 1.44B |
Related stock screener links
About BIO.DE
Company Profile
Biotest AG is a DE-based company operating in Biotechnology industry. The company is headquartered in Dreieich, Hessen and currently employs 2,426 full-time employees. Biotest AG is a Germany-based provider of plasma proteins and biological drugs. The Company, with a chain that extends from pre-clinical and clinical development to worldwide marketing and distribution, mainly specializes in the areas of clinical immunology, hematology, and intensive care medicine. The company develops, manufactures, and markets immunoglobulin, coagulation factors, and albumins based on human blood plasma. These are used for diseases of the immune and hematopoietic systems. In addition, the Company develops monoclonal antibodies in the indications of cancer of plasma cells and systemic lupus erythematosus, which are produced by recombinant technologies.
Company Info
BIOTEST AG
Landsteinerstr. 5
Dreieich HESSEN DE
Employees: 2426
Company Website: https://www.biotest.com/
Phone: 4961038010
BIO.DE FAQ
What is the stock price of BIO.DE?
The current stock price of BIO.DE is 40.8 EUR.
What is the symbol for BIOTEST AG stock?
The exchange symbol of BIOTEST AG is BIO and it is listed on the Deutsche Boerse Ag exchange.
On which exchange is BIO.DE stock listed?
BIO.DE stock is listed on the Deutsche Boerse Ag exchange.
Is BIO.DE a good stock to buy?
Always make your own analysis. On these pages you can find a full technical and fundamental analysis report for BIO.DE, which may be a starting point for your analysis. You can also find the financials, news, analyst ratings and estimates here, which can be used to increase your understanding of BIO.DE.
Does BIO.DE stock pay dividends?
BIO.DE does not pay a dividend.
What is the Price/Earnings (PE) ratio of BIO.DE?
The PE ratio for BIO.DE is 23.86. This is based on the reported non-GAAP earnings per share of 1.71 and the current share price of 40.8 EUR.
BIO.DE Technical Analysis
ChartMill assigns a technical rating of 2 / 10 to BIO.DE. When comparing the yearly performance of all stocks, BIO.DE is a bad performer in the overall market: 77.88% of all stocks are doing better.
BIO.DE Fundamental Analysis
ChartMill assigns a fundamental rating of 4 / 10 to BIO.DE. While BIO.DE is still in line with the averages on profitability rating, there are concerns on its financial health.
BIO.DE Financial Highlights
Over the last trailing twelve months BIO.DE reported a non-GAAP Earnings per Share(EPS) of 1.71. The EPS decreased by 32.7% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | 9.69% | ||
| ROA | 5.09% | ||
| ROE | 12.99% | ||
| Debt/Equity | 0.82 |
BIO.DE Ownership and Analysts
ChartMill assigns a Buy % Consensus number of 46% to BIO.DE. The Buy consensus is the average rating of analysts ratings from 7 analysts.
For the next year, analysts expect an EPS growth of -103.15% and a revenue growth -6.17% for BIO.DE